Preparation and Characterization of Poliglecaprone-Incorporated Polycaprolactone Composite Fibrous Scaffolds

Abstract

Electrospun fibrous scaffolds made from polymers such as polycaprolactone (PCL) have been used in drug delivery and tissue engineering for their viscoelasticity, biocompatibility, biodegradability, and tunability. Hydrophobicity and the prolonged degradation of PCL causes inhibition of the natural tissue-remodeling processes. Poliglecaprone (PGC), which consists of PCL and Poly (glycolic acid) (PGA), has better mechanical properties and a shorter degradation time compared to PCL. A blend between PCL and PGC called PPG can give enhanced shared properties for biomedical applications. In this study, we fabricated a blend of PCL and PGC nanofibrous scaffold (PPG) at different ratios of PGC utilizing electrospinning. We studied the physicochemical and biological properties, such as morphology, crystallinity, surface wettability, degradation, surface functionalization, and cellular compatibility. All PPG scaffolds exhibited good uniformity in fiber morphology and improved mechanical properties. The surface wettability and degradation studies confirmed that increasing PGC in the PPG composites increased hydrophilicity and scaffold degradation respectively. Cell viability and cytotoxicity results showed that the scaffold with PGC was more viable and less toxic than the PCL-only scaffolds. PPG fibers were successfully coated with polydopamine (PDA) and collagen to improve degradation, biocompatibility, and bioactivity. The nanofibrous scaffolds synthesized in this study can be utilized for tissue engineering applications such as for regeneration of human articular cartilage regeneration and soft bones.